Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Azioni
  3. Stati Uniti
  4. Nasdaq
  5. Exicure, Inc.
  6. Notizie
  7. Altre lingue
    XCUR   US30205M1018

EXICURE, INC.

(XCUR)
Prezzo stimato in tempo reale. Tempo reale stimato Cboe BZX - 29/11 15:49:03
0.505 USD   +1.90%
12/08Flash dei guadagni (XCUR) EXICURE Posts Q2 entrate $79.000
MT
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su EXICURE, INC.
23/11EXICURE ALERT: Bragar Eagel & Squire, P.C. is Investigating Exicure, Inc. on Behalf of Ex..
22/11Exicure, Inc. Reports Third Quarter 2021 Financial Results and Corporate Progress
20/11Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investi..
20/11INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Exicure, In..
19/11EXICURE: Reports Third Quarter 2021 Financial Results and Corporate Progress - Form 8-K
19/11EXICURE, INC. Management's Discussion and Analysis of Financial Condition and Results ..
19/11Exicure, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
19/11Exicure, Inc. Reports Third Quarter 2021 Financial Results and Corporate Progress
18/11INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ..
17/11INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Exi..
17/11EQUITY ALERT: Rosen Law Firm Encourages Exicure, Inc. Investors with Losses in Excess of ..
17/11Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigati..
16/11The Law Offices of Frank R. Cruz Announces Investigation of Exicure, Inc. (XCUR) on Beh..
16/11INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Exicure, Inc. (..
16/11Exicure, Inc. - Exicure Files Form 12b-25
15/11Exicure Files Form 12b-25
28/10Exicure to Present at Upcoming Scientific Conferences
07/10EXICURE: to Present at Upcoming Scientific Conferences
06/10EXICURE: AMENDMENT NO. 3 TO CREDIT AND SECURITY AGREEMENT (Form 8-K)
06/10EXICURE, INC.: Entry into a Material Definitive Agreement, Creation of a Direct Financial..
04/10EXICURE: to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
23/09EXICURE: to Present at the Benzinga Healthcare Small Cap Conference
15/09EXICURE: to Participate in Upcoming Scientific Conferences
01/09EXICURE: to Participate in Upcoming Investor Conferences
12/08EXICURE: Management's Discussion and Analysis of Financial Condition and Results of Opera..
12/08EXICURE: Presented Progress in Three Promising Neuroscience Programs including Friedreich..
12/08EXICURE: Earnings Flash (XCUR) EXICURE Posts Q2 Revenue $79,000
12/08EXICURE, INC.: Reports Second Quarter 2021 Financial Results and Corporate Progress
11/08NORTH AMERICAN MORNING BRIEFING: Investors Await -2-
06/08EXICURE: Provides Interim Results from Ongoing Phase 1b/2 Clinical Trial of Cavrotolimod
05/08EXICURE INC: . to Present at the BTIG Virtual Biotechnology Conference
05/08EXICURE, INC.: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ..
05/08EXICURE: Provides Interim Results from Ongoing Phase 1b/2 Clinical Trial of Cavrotolimod ..
05/08Exicure Provides Interim Results from Ongoing Phase 1b/2 Clinical Trial of Cavrotolimod
04/08EXICURE, INC.: to Present at the BTIG Virtual Biotechnology Conference
02/08Top Midday Gainers
02/08GLOBAL MARKETS LIVE: Square, Pfizer, Zoom, HSBC, Ferrari
02/08EXICURE: Working With Ipsen to Develop Potential Therapeutics for Neurodegenerative Disor..
02/08EXICURE: Thinking about buying stock in Exicure, Orbital Energy, Vaxart, Li Auto, or RA M..
02/08EXICURE: Material Definitive Agreement (Form 8-K)
02/08EXICURE, INC.: Entry into a Material Definitive Agreement, Financial Statements and Exhib..
02/08Les valeurs à suivre aujourd'hui à Paris Lundi 2 août 2021
02/08IPSEN: signe un partenariat avec Exicure dans les acides nucléiques sphériques
02/08IPSEN: Exicure to Develop Treatment for Neurodegenerative Illnesses
02/08EN DIRECT DES MARCHES: Axa, Bolloré, Neoen, Ipsen, HSBC, Heineken, Square, Moderna...
02/08IPSEN: accord de collaboration avec Exicure
02/08IPSEN: partenariat exclusif avec Exicure dans les maladies neurodégénératives rares
02/08Dernière ligne droite avant la coupure aoûtienne
02/08EXICURE: Ipsen conclut un partenariat exclusif avec Exicure dans les maladies neurodégéné..
02/08EXICURE: Ipsen and Exicure Enter Into Exclusive Collaboration Targeting Rare Neurodegener..
15/07EXICURE, INC.: Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
08/07EXICURE: Announces Upcoming Neuroscience Pipeline Update at Virtual R&D Day
29/06EXICURE, INC.: to Present at Ladenburg Thalmann 2021 Healthcare Conference
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell 3000E Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell Small Cap Completeness Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell Small Cap Comp Value Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell 3000 Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell 3000E Growth Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell 2000 Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell Microcap Value Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell 3000E Value Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell 2000 Growth Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell 2500 Growth Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell 3000 Value Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell 2500 Value Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell 3000 Growth Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell Small Cap Comp Growth Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell 2000 Value Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell 2500 Index
25/06EXICURE, INC.(NASDAQCM: XCUR) dropped from Russell 2000 Dynamic Index
03/06EXICURE: Departure of Directors or Certain Officers; Election of Directors; Appointment o..
03/06EXICURE, INC.: Change in Directors or Principal Officers (form 8-K)
03/06Exicure, Inc. Appoints Elias D. Papadimas as Chief Accounting Officer
03/06EXICURE, INC.: Announces Participation in Upcoming Conferences
02/06EXICURE, INC.: Submission of Matters to a Vote of Security Holders (form 8-K)
1  2  3  4Pross.
Prossimo evento su EXICURE, INC.
10/03/22